Navigation Links
U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma
Date:10/30/2009

reates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE: The information in this media alert includes certain "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995, including statements relating to clinical development of investigational oncology compounds. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the Company's third quarter 2009 10-Q, filed October 29, 2009.

SOURCE Schering-Plough Corporation


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
2. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
3. Australian Therapeutics Goods Administration Approval for ActiPatch Achieved
4. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
5. Korean Food and Drug Administration Approval for ActiPatch Achieved
6. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
7. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 With the ability to record continuously ... more than 15 minutes, Fastec Imaging has brought the same ... speed imaging. “Finally, a high speed camera that can be ... our everyday lives.” proclaims Matt Kearney, VP of Sales for ... to demystify and simplify the traditionally complicated workflow of a ...
(Date:7/23/2014)... MD (PRWEB) July 23, 2014 a2z ... and ChirpE Mobile App, AACC Pathfinder, in its ... offerings. AACC’s annual meeting is planned for July 29-31, ... the place to be to connect with global leaders ... lab management, and other areas of breaking science in ...
(Date:7/23/2014)... Astra Nova Training , ... and pharma training services, and the Alliance ... a non-profit integrating the expertise and investments of ... global system for clinical trials, are pleased to ... expertise of industry professionals through improved and easily ...
(Date:7/22/2014)... , July 22, 2014 The Board of Directors ... ) has declared a quarterly dividend of 54.5 cents per ... record on September 9, 2014. The indicated annual dividend rate ... BD is a leading medical technology company that partners ... most pressing and evolving health needs. Our innovative solutions are ...
Breaking Biology Technology:Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 2Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals 3
... , Madison, Wis. Battery and household products manufacturer ... St. Louis-based firm United Industries for $1.2 billion dollars of ... in February. The deal will give Rayovac an increased foothold ... such as Spectracide, Vigoro and Sta-Green. , Inacom joins EMC ...
... Spence, a physics graduate student, and Roch Kendrick, a ... clothing while working on equipment used for the Madison ... Photo courtesy of UW-Madison. In an underground bunker ... side, and a cornfield on the other, a team ...
... satellite. Courtesy of UW-Madison. Madison, Wis. ... the University of Wisconsin's Cooperative Institute for Meteorological ... institute has begun testing its weather forecast data using ... Silicon Graphics Inc. , a company headquartered in California ...
Cached Biology Technology:Tech Digest: Rayovac, Inacom, TomoTherapy, Regal-Beloit, Modine 2Earth's core modeled in underground experiment 2Earth's core modeled in underground experiment 3UW-Madison picks scalable SGI computer to simulate weather 2UW-Madison picks scalable SGI computer to simulate weather 3
(Date:7/23/2014)... disease, the devastating neurological disease affecting more than ... new progress on a set of compounds, initially ... a potential oral therapy for Alzheimer,s. Their study ... . , Carlo Ballatore, Kurt R. Brunden and ... protein known as tau binds to and stabilizes ...
(Date:7/23/2014)... and blood-brain barrier damage appear after cerebral ... Matrix metalloproteinase-9 is able to degrade the ... cerebral blood vessels and to mediate extracellular ... colleagues from the First Affiliated Hospital of ... induced cerebral infarction in stroke-prone spontaneously hypertensive ...
(Date:7/23/2014)... is available in German . ... Max Planck Institute of Molecular Cell Biology and ... capture detailed three-dimensional images of cardiac dynamics in ... Plane Illumination Microscopy (SPIM) and clever image processing ... heart. Furthermore, they have developed a method of ...
Breaking Biology News(10 mins):Unbreak my heart 2
... sequence the genome of a microbiological master of ... scientists because they are able to live under ... concentrations, high pH-values, or high temperatures. Nature's masters ... researchers can draw conclusions about the first organisms ...
... Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute ... have now added key evidence to claims that some types ... reported this week in the on-line edition of Nature ... placed in the right locations within stem cells before they ...
... melanoma this year, says the American Cancer Society, and ... caught in the early stages, melanoma can be a ... with an efficiency that few tumors possess. Now, researchers ... of the reasons why this particular skin tumor is ...
Cached Biology News:Life in deadly conditions 2Life in deadly conditions 3A new link between stem cells and tumors 2Researchers discover why melanoma is so malignant 2Researchers discover why melanoma is so malignant 3